Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes.

Campagne FAMILLE SANS FUMÉE du 26 août au 6 octobre
septembre 9, 2019
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial
septembre 16, 2019

Recent evidence suggests that cannabis use during pregnancy is increasing, although
population-based data about perinatal outcomes following in utero exposure remain limited.
To assess whether there are associations between self

Laisser un commentaire

Votre adresse courriel ne sera pas publiée. Les champs obligatoires sont indiqués avec *